Clinical Trials on Immune System Processes in China

Total 19920 results

Nanjing First Hospital, Nanjing Medical University

Completed

The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis

Sepsis | Enteral Feeding | Immune System Disorder

China
Guangdong Provincial Hospital of Traditional Chinese...

Completed

Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis (EAIm-sepsis)

Sepsis | Immune Dysfunction

China
Suez Canal University

Recruiting

Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis (BIS6)

Sepsis, Severe

China
Second Affiliated Hospital, School of Medicine,...

Completed

The Study of NT-proBNP Combined With HS-cTnT in Evaluating the Prognosis of Sepsis

Sepsis

China
LI Taisheng

Unknown

Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders (CACTrip12)

HIV

China
Shanghai Public Health Clinical Center

Recruiting

Study of MDW Levels Predicting the Development of Sepsis in Hospitalized HIV-infected Patients and Correlation With Prognosis

HIV Infections | Sepsis

China
Peking University People's Hospital

Unknown

Interferon α for the Therapy of Minimal Residual Disease

Leukemia

China
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Left Ventricular Global Longitudinal Strain and Postoperative Myocardial Injury

Postoperative Complications

China
Ruijin Hospital

Recruiting

Effect of Telitacicept on Antibody Titers in Primary APS Patients

Antiphospholipid Syndrome (APS)

China
Peking University People's Hospital

Recruiting

Placental Pathology and Inflammatory Factor Analysis of OAPS

Antiphospholipid Syndrome in Pregnancy

China
Hebei Medical University

Recruiting

Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer

Leptomeningeal Metastasis | Immune Checkpoint Inhibitor | Endostatin

China
Shenzhen Geno-Immune Medical Institute

Unknown

Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders

Tissue Damage | Immune Related Disorder

China
Ruijin Hospital

Completed

Accurate Diagnosis of Multiple Sclerosis Using PET/MR

Multiple Sclerosis

China
Peking University

Recruiting

R-MTX-zanbrutinib in Secondary CNS Lymphoma

Secondary Central Nervous System Lymphoma

China
RenJi Hospital

Unknown

Accuracy, Feasibility and Acceptance of CGM Lupus

Critical Illness | Systemic Lupus Erythematosus | Diabetic Blood Glucose Monitoring

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Nantong University; Tianjin Medical University Second... and other collaborators

Unknown

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Primary Immune Thrombocytopenia (ITP)

China
Peking University First Hospital
Peking University People's Hospital; Peking University Third Hospital; Peking... and other collaborators

Unknown

Combination Therapy Prevents the Relapse of RA

Recurrence (Disease Attribute)

China
Institute of Hematology & Blood Diseases Hospital...
Henan Cancer Hospital; Beijing Children's Hospital; Tianjin Medical University... and other collaborators

Recruiting

TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

Primary Immune Thrombocytopenia (ITP)

China
Bayer

Completed

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

Multiple Sclerosis

China
Sun Yat-sen University
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

Characteristic Study on Chinese Patients With Multiple Sclerosis

Multiple Sclerosis

China
Institute of Hematology & Blood Diseases Hospital

Recruiting

TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years (ITP)

Primary Immune Thrombocytopenic Purpura

China
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....

Withdrawn

A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple Sclerosis

Relapsing Multiple Sclerosis

China
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

HIV Infections | HIV-1-infection | PD-L1 Gene Mutation

China
Peking University People's Hospital

Unknown

Low-dose IL-2 ( Interleukin-2) Treatment in Macrophage Activation Syndrome（MAS）

Macrophage Activation Syndrome

China
Institute of Hematology & Blood Diseases Hospital...
Henan Cancer Hospital; Beijing Children's Hospital; Tianjin Medical University... and other collaborators

Recruiting

Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)

Primary Immune Thrombocytopenia

China
Shanghai 10th People's Hospital

Unknown

the Relationship of the Use of Eye Masks and Outcomes of Patients With Sepsis in Intensive Care Unit

Sepsis | Sleep Deprivation | Immune Suppression

China
Hutchison Medipharma Limited

Unknown

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

Immune Thrombocytopenia (ITP)

China
Shanghai Henlius Biotech

Completed

Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects

Immune System Disorder

China
Qilu Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Primary Immune Thrombocytopenia

China
Institute of Hematology & Blood Diseases Hospital...
Henan Cancer Hospital; The Second Affiliated Hospital of Kunming Medical University and other collaborators

Completed

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia (ITP)

Immune Thrombocytopenic Purpura

China
Sanofi

Completed

Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia (RAISE)

Lymphoma

China
Chinese PLA General Hospital

Recruiting

CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL

CD19+ Relapse/Refractory B-ALL

China
Institute of Hematology & Blood Diseases Hospital

Active, not recruiting

Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

Thrombocytopenia | Mesenchymal Stem Cells

China
920th Hospital of Joint Logistics Support Force...

Recruiting

Efficacy and Safety of CAR-T Cells Therepy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)

ITP - Immune Thrombocytopenia

China
Shandong University
West China Hospital; Jinan Military General Hospital; Shandong University of... and other collaborators

Completed

Autoantibody Specificity and Response to IVIG in ITP

Immune Thrombocytopenia (ITP)

China
Wuhan Union Hospital, China
The First Affiliated Hospital of Nanchang University; The Third Xiangya Hospital... and other collaborators

Unknown

Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) ((ITP;rhTPO))

Primary Immune Thrombocytopenia

China
Second Affiliated Hospital, School of Medicine,...
The First Affiliated Hospital of Nanchang University; RenJi Hospital; Ningbo... and other collaborators

Recruiting

A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)

Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Primary Immune Thrombocytopenic Purpura

China
Shandong University

Recruiting

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

ITP - Immune Thrombocytopenia

China
Shandong University

Recruiting

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Primary Immune Thrombocytopenia

China
RemeGen Co., Ltd.

Recruiting

RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial

Multiple Sclerosis, Relapsing-Remitting

China
First Affiliated Hospital of Suzhou Medical College

Completed

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenic Purpura

China
Institute of Hematology & Blood Diseases Hospital

Recruiting

Anti-CD38 Antibody Treating APS With Thrombocytopenia

Thrombocytopenia | Antiphospholipid Syndrome

China
Peking Union Medical College Hospital
The Second Hospital of Hebei Medical University; Tianjin Medical University...

Recruiting

Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis

Autoimmune Pancreatitis

China
Peking University People's Hospital
Peking University First Hospital; Beijing Friendship Hospital; Chinese PLA General... and other collaborators

Recruiting

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital
Qilu Hospital of Shandong University; Beijing Tongren Hospital; Beijing Hospital and other collaborators

Not yet recruiting

Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Recruiting

The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy

Immune Thrombocytopenia

China
Peking University People's Hospital

Not yet recruiting

Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China
Peking University People's Hospital

Not yet recruiting

A Study of Orelabrutinib in Patients With ITP

Immune Thrombocytopenia

China
Peking University People's Hospital

Not yet recruiting

The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia

China

Clinical Trials on Immune System Processes in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations